IT
Inserm Transfert Initiative
Angel InvestorActiveInserm Transfert Initiative is a seed stage life science vehicle currently managing about √ҐвАЪ¬ђ4.2M for the financing of new biotech
20
Investments
3
Exits
—
AUM
15.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Inserm Transfert Initiative.
Investment Thesis & Strategy
Inserm Transfert Initiative invests in seed-stage biotech companies, specifically focusing on life science ventures, with a focus on financing new biotech.
Investment Activity
Deals per year over the last 7 years
2
20153
20161
20171
20181
20190
20201
2021Portfolio Companies
Selected investments from their portfolio of 20 companies
I
InHeart
Biotech · Seed, 2021
I
InnoSkel
Biotech · Series A, 2019
C
Cardiawave
Biotech · Series A, 2018
B
BioTech Dental
Biotech · Growth, 2017
P
Pixium Vision
Biotech · Growth, 2016
O
OSE Immunotherapeutics
Biotech · Growth, 2016
S
Stilla Technologies
Biotech · Series B, 2016
H
Horama
Biotech · Series A, 2015
I
ImCheck Therapeutics
Biotech · Series A, 2015
Frequently Asked Questions
Inserm Transfert Initiative focuses on Pre-seed, Seed stage investments.